Growth Metrics

Bristol Myers Squibb (BMYMP) Tax Provisions (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Tax Provisions for 17 consecutive years, with $384.0 million as the latest value for Q4 2025.

  • Quarterly Tax Provisions rose 287.88% to $384.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 billion through Dec 2025, up 310.11% year-over-year, with the annual reading at $2.3 billion for FY2025, 310.11% up from the prior year.
  • Tax Provisions for Q4 2025 was $384.0 million at Bristol Myers Squibb, down from $919.0 million in the prior quarter.
  • The five-year high for Tax Provisions was $919.0 million in Q3 2025, with the low at -$514.0 million in Q4 2021.
  • Average Tax Provisions over 5 years is $283.9 million, with a median of $432.0 million recorded in 2022.
  • The sharpest move saw Tax Provisions crashed 141.21% in 2023, then soared 287.88% in 2025.
  • Over 5 years, Tax Provisions stood at -$514.0 million in 2021, then skyrocketed by 67.7% to -$166.0 million in 2022, then skyrocketed by 46.99% to -$88.0 million in 2023, then skyrocketed by 212.5% to $99.0 million in 2024, then skyrocketed by 287.88% to $384.0 million in 2025.
  • According to Business Quant data, Tax Provisions over the past three periods came in at $384.0 million, $919.0 million, and $460.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.